Lack of benefit of 5-fluorouracil-based adjuvant chemotherapy in colorectal cancer with microsatellite instability.
作者信息
Johnson Lori, Chu Edward
出版信息
Clin Colorectal Cancer. 2002 Nov;2(3):146-8. doi: 10.1016/S1533-0028(11)70320-6.
Abstract
摘要
相似文献
1
Lack of benefit of 5-fluorouracil-based adjuvant chemotherapy in colorectal cancer with microsatellite instability.
Clin Colorectal Cancer. 2002 Nov;2(3):146-8. doi: 10.1016/S1533-0028(11)70320-6.
2
3
p53 is an independent pre-treatment markers for long-term survival in stage II and III colorectal cancers: an analysis of interaction between genetic markers and fluorouracil-based adjuvant therapy.
Cancer Lett. 2004 Jul 8;210(1):101-9. doi: 10.1016/j.canlet.2004.01.006.
4
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.
N Engl J Med. 2003 Jul 17;349(3):247-57. doi: 10.1056/NEJMoa022289.
5
Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma.
Clin Colorectal Cancer. 2001 Aug;1(2):104-9. doi: 10.3816/CCC.2001.n.010.
6
Predictive value of microsatellite instability for benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.
Gut. 2006 Dec;55(12):1819-20. doi: 10.1136/gut.2006.105627.
7
Microsatellite instability in colon cancer.
N Engl J Med. 2003 Oct 30;349(18):1774-6; author reply 1774-6. doi: 10.1056/NEJM200310303491818.
8
Tumour site, sex, and survival in colorectal cancer.
Lancet. 2000 Sep 2;356(9232):857; author reply 858. doi: 10.1016/S0140-6736(05)73439-5.
9
Biologic behavior of microsatellite-unstable colorectal cancer and treatment with 5-fluorouracil.
Isr Med Assoc J. 2005 Aug;7(8):520-4.
10
Tumour site, sex, and survival in colorectal cancer.
Lancet. 2000 Sep 2;356(9232):857; author reply 858. doi: 10.1016/S0140-6736(05)73438-3.
Zotero 插件